- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03112057
Visualize Nociceptor Changes in Neuropathic Human
Study Overview
Status
Intervention / Treatment
Detailed Description
This study will be the skin tissue for the virtual slice object, the study intends to the following research:
The number of people enrolled in the Court is 170.
Between 20 and 90 years old, meet the following conditions, suitable for participation in this test:
- Healthy subjects of different ages (20 persons): to study the optical imaging of the skin and nerve endings: the control of healthy subjects and peripheral neuropathy patients skin observed by the optical images of the shoots.
- Abandoned extra digit specimen of polydactyly(10 persons): to study the optical imaging of the normal skin and nerve endings in extra digit : collect abandoned digit specimen after surgical removal in polydactyly.
- has been diagnosed with peripheral neuropathy (90 persons):to study the diagnosis of peripheral neuropathy of the skin nerve endings of the optical image observation and quantitative sensory nerve examination
- clinically must be diagnosed by the skin slices of diabetic neuropathy patients have been removed after the completion of clinical diagnosis of the specimen,And then the skin slices of the nerve endings of the optical image observation (20 persons):study the technical observation of diabetic patients with skin sections of the nerve endings of the optical image observation: the clinical must be skin slices for the diagnosis of diabetic neuropathy, patients has been taken out after the completion of clinical diagnosis, and then the skin slices of the nerve endings of the light learning image observation.
- because of chemotherapy during chemotherapy, is expected to have peripheral neuropathy: before the occurrence of peripheral neuropathy , Peripheral nerve lesions were cured after subcutaneous nerve optical observation (30 persons):for different periods of peripheral neuropathy subcutaneous nerve optical observation: in the peripheral neuropathy occurred before the occurrence of peripheral neuropathic symptoms, peripheral neuropathy after cure for subcutaneous nerve optical observation.
This test can not be attended if:
Those who suffer from systemic infection or have been infected with the site by the physician assessment is not suitable for examination.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy subjects of different ages
- abandoned extra digit specimen in polydactyly
- diagnosed with peripheral neuropathy
- diabetic neuropathy patients have been removed after the completion of clinical diagnosis of the specimen, And then the skin slices of the nerve endings of the optical image observation
- because of chemotherapy during chemotherapy, is expected to have peripheral neuropathy: before the occurrence of peripheral neuropathy , after cured peripheral nerve lesions
Exclusion Criteria:
- systemic infection or have been infected with the site by the physician assessment is not suitable for examination.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Healthy subjects
Healthy subjects of different ages (20 persons), Interventions: harmonic generation microscopy
|
a frequency-dependent optical microscopy system with a near-infrared light source with a wavelength of 1230 nm was used to detect the diseased site and normal skin.Use erbium-Jacob (Er-YAG) laser exfoliation.
the participants need to lie down, wear goggles.
The lens sucker device to help fix the skin examination site.
Based on the experience of the past 118 subjects, the participants did not discomfort.
The total time of the laser irradiation on the same skin is no more than 30 minutes, the maximum laser power is no more than 0.15 watts, irradiation in the skin of the total energy of the laser does not exceed 270 joules.
After the experiment, the investigators immediately check the skin for the participants
|
|
EXPERIMENTAL: peripheral neuropathy
the participant have symptoms and diagnosed with peripheral neuropathy (90 persons), Interventions:harmonic generation microscopy
|
a frequency-dependent optical microscopy system with a near-infrared light source with a wavelength of 1230 nm was used to detect the diseased site and normal skin.Use erbium-Jacob (Er-YAG) laser exfoliation.
the participants need to lie down, wear goggles.
The lens sucker device to help fix the skin examination site.
Based on the experience of the past 118 subjects, the participants did not discomfort.
The total time of the laser irradiation on the same skin is no more than 30 minutes, the maximum laser power is no more than 0.15 watts, irradiation in the skin of the total energy of the laser does not exceed 270 joules.
After the experiment, the investigators immediately check the skin for the participants
|
|
EXPERIMENTAL: diabetic neuropathy
the participant have symptoms and diagnosed with diabetic neuropathy (20 persons), Interventions:harmonic generation microscopy
|
a frequency-dependent optical microscopy system with a near-infrared light source with a wavelength of 1230 nm was used to detect the diseased site and normal skin.Use erbium-Jacob (Er-YAG) laser exfoliation.
the participants need to lie down, wear goggles.
The lens sucker device to help fix the skin examination site.
Based on the experience of the past 118 subjects, the participants did not discomfort.
The total time of the laser irradiation on the same skin is no more than 30 minutes, the maximum laser power is no more than 0.15 watts, irradiation in the skin of the total energy of the laser does not exceed 270 joules.
After the experiment, the investigators immediately check the skin for the participants
|
|
EXPERIMENTAL: chemotherapy induced neuropathy
before chemotherapy, during chemotherapy, after peripheral nerve lesions were cured (30 persons).
Interventions:harmonic generation microscopy
|
a frequency-dependent optical microscopy system with a near-infrared light source with a wavelength of 1230 nm was used to detect the diseased site and normal skin.Use erbium-Jacob (Er-YAG) laser exfoliation.
the participants need to lie down, wear goggles.
The lens sucker device to help fix the skin examination site.
Based on the experience of the past 118 subjects, the participants did not discomfort.
The total time of the laser irradiation on the same skin is no more than 30 minutes, the maximum laser power is no more than 0.15 watts, irradiation in the skin of the total energy of the laser does not exceed 270 joules.
After the experiment, the investigators immediately check the skin for the participants
|
|
EXPERIMENTAL: Polydactyly
Abandoned extra digit specimen of polydactyly(10 persons): the normal skin and nerve endings in extra digit: Interventions: harmonic generation microscopy
|
a frequency-dependent optical microscopy system with a near-infrared light source with a wavelength of 1230 nm was used to detect the diseased site and normal skin.Use erbium-Jacob (Er-YAG) laser exfoliation.
the participants need to lie down, wear goggles.
The lens sucker device to help fix the skin examination site.
Based on the experience of the past 118 subjects, the participants did not discomfort.
The total time of the laser irradiation on the same skin is no more than 30 minutes, the maximum laser power is no more than 0.15 watts, irradiation in the skin of the total energy of the laser does not exceed 270 joules.
After the experiment, the investigators immediately check the skin for the participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
nerve ending number measurement
Time Frame: through study completion, an average of 1 year
|
Use of harmonic generation (HGM) microscopic virtual biopsy methods to obtain 3D live images.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
nerve ending structure measurement
Time Frame: through study completion, an average of 1 year
|
Quantify the molecules on the image, the biological characteristics of tissue nerve cells have a comprehensive understanding, and will try to establish the human subcutaneous nerve optical observation method
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201610037DINC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Neuropathy
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingChemotherapy-Induced Peripheral Neuropathy | Paclitaxel-Induced Peripheral Neuropathy | Refractory Chemotherapy-Induced Peripheral Neuropathy
-
Arash Asher, MDVoxxLifeCompletedNeuropathy | Chemotherapy-induced Peripheral Neuropathy | Neuropathy;PeripheralUnited States
-
Dana-Farber Cancer InstitutePaxman Coolers LimitedRecruitingChemotherapy-induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral Neuropathy | Taxane-Induced Peripheral NeuropathyUnited States
-
Dana-Farber Cancer InstituteRecruitingNeuropathy | Peripheral Neuropathies | Peripheral Neuropathy Due to Chemotherapy | Chemotherapy Induced Peripheral Neuropathy (CIPN)United States
-
Beth Israel Deaconess Medical CenterPhoenix Neurological Associates, LTDCompletedSmall Fiber Neuropathy | Idiopathic Peripheral NeuropathyUnited States
-
Case Comprehensive Cancer CenterVelaSanoRecruitingChemotherapy-induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral NeuropathyUnited States
-
University of RochesterBeth Israel Deaconess Medical CenterRecruitingIdiopathic Peripheral Neuropathy | Chemotherapy Induced Peripheral Neuropathy (CIPN) | Painful Peripheral Neuropathy | Diabetic Peripheral Neuropathic Pain (DPN)United States
-
M.D. Anderson Cancer CenterFoundation for Anesthesia Education and ResearchActive, not recruitingNeuropathy;PeripheralUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Tarian PharmaNot yet recruitingChemotherapy Induced Peripheral NeuropathyFrance
Clinical Trials on harmonic generation (HGM) microscopic methods.
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanRecruitingHealthy Participants With Different Skin Types and Different Ages | Diseased Participants With Different Skin Types and Different Ages | Participants Suffered From Diabetes With Different Skin Types and Different AgesTaiwan
-
Yael P MosseNovartis Pharmaceuticals; Foundation MedicineTerminated